Category Archives: Consumer Goods

Monday’s Highlights at Noon: Brainstorm Cell Therapeutics (BCLI), Xoma (XOMA), SunPower (SPWR), Karyopharm Therapeutics (KPTI), Blueprint Medicines (BPMC)

So far Monday, February 17, NASDAQ is down -2.8% and the S&P is up 0.09%. Here are this morning’s most active stocks: Brainstorm Cell Therapeutics (BCLI – Research Report), Xoma (XOMA – Research Report), SunPower (SPWR – Research Report), Karyopharm

Molson Coors (TAP) Receives a Sell from Credit Suisse

Credit Suisse analyst Kaumil Gajrawala maintained a Sell rating on Molson Coors (TAP – Research Report) on February 13 and set a price target of $46.00. The company’s shares closed last Monday at $55.25. According to TipRanks.com, Gajrawala is a

Xperi (XPER) Receives a Buy from B.Riley FBR

B.Riley FBR analyst Eric Wold reiterated a Buy rating on Xperi (XPER – Research Report) on February 14 and set a price target of $28.00. The company’s shares closed last Monday at $15.23, close to its 52-week low of $14.97.

Needham Remains a Buy on Lantronix (LTRX)

In a report issued on February 13, Richard Valera from Needham maintained a Buy rating on Lantronix (LTRX – Research Report), with a price target of $4.25. The company’s shares closed last Monday at $3.36. According to TipRanks.com, Valera is

NetApp (NTAP) Gets a Buy Rating from Maxim Group

Maxim Group analyst Nehal Chokshi reiterated a Buy rating on NetApp (NTAP – Research Report) on February 13 and set a price target of $74.00. The company’s shares closed last Monday at $54.24. According to TipRanks.com, Chokshi is a 4-star

Maxim Group Keeps Their Buy Rating on Turtle Beach (HEAR)

In a report issued on February 13, Nehal Chokshi from Maxim Group maintained a Buy rating on Turtle Beach (HEAR – Research Report), with a price target of $16.00. The company’s shares closed last Monday at $7.20, close to its